HGC Urges UK to Review Biomarker Patent Policies | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The UK needs to start developing a plan to review its policies and practices regarding DNA and biomarker patents and how these programs are monitored and managed, according to a new report issued by the Human Genetics Commission.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: ProTraits includes genetic, phenotypic data on bacteria, archaea; Candida albicans assembly 22; and more.

The Wall Street Journal reports that researchers are looking beyond Cas9 for CRISPR editing.

Familial DNA searches in criminal cases are winning over some critics, the Los Angeles Times reports.

Genomics may help the Cavendish banana from succumbing to fungal infections, a trio of researchers writes at the Conversation.